2017-67-6 Usage
Uses
Used in Pharmaceutical Synthesis:
2-(2-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE is used as a reagent for the synthesis of various pharmaceutical compounds, contributing to the development of new medications due to its unique chemical structure and properties.
Used in Organic Compounds Synthesis:
In the realm of organic chemistry, 2-(2-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE serves as a reagent in the synthesis of a range of organic compounds, broadening its applications across different chemical industries.
Used in Dye and Pigment Production:
2-(2-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE is utilized as an intermediate in the production of dyes and pigments, enhancing the color characteristics and performance of these materials in various applications.
Used in Chemical Reactions and Processes:
Owing to its improved solubility, 2-(2-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE is used in a variety of chemical reactions and processes, where its water-soluble nature simplifies handling and integration into complex chemical procedures.
Safety Considerations:
It is crucial to handle 2-(2-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE with care, as it may pose risks if ingested, inhaled, or comes into contact with the skin, emphasizing the need for proper safety measures during its use.
Check Digit Verification of cas no
The CAS Registry Mumber 2017-67-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,1 and 7 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2017-67:
(6*2)+(5*0)+(4*1)+(3*7)+(2*6)+(1*7)=56
56 % 10 = 6
So 2017-67-6 is a valid CAS Registry Number.
2017-67-6Relevant academic research and scientific papers
Novel compounds and compositions for treating diseases asociated with protease activity
-
, (2008/06/13)
Novel compounds, compositions and methods effective for the prevention and treatment of mast-cell mediated inflammatory disorders are described. The compounds, compositions and methods are effective for the prevention and treatment of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, as well as other types of immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis and inflammatory bowel disease, various dermatological conditions, as well as certain viral conditions. The compounds comprise potent and selective inhibitors of the mast cell protease tryptase. The compositions for treating these conditions include oral, inhalant, topical and parenteral preparations as well as devices comprising such preparations.
Low molecular weight peptidomimetic growth hormone secretagogues
-
, (2008/06/13)
The present invention comprises growth hormone releasing peptides/peptidomimetics (GHRP) capable of causing release of growth hormone from the pituitary. Compositions containing the GHRP's of this invention are used to promote growth in mammals either alone or in combination with other growth promoting compounds, especially IGF-1. In a method of this invention GHRP's in combination with IGF-1 are used to treat Type II diabetes. An exemplary compound of this invention is provided below. STR1
